109 related articles for article (PubMed ID: 38530780)
1. Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.
Yoshida H; Magi M; Tamai H; Kikuchi J; Yoshimoto K; Otomo K; Matsumoto Y; Noguchi-Sasaki M; Takeuchi T; Kaneko Y
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38530780
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
Kikuchi J; Hashizume M; Kaneko Y; Yoshimoto K; Nishina N; Takeuchi T
Arthritis Res Ther; 2015 Jan; 17(1):10. PubMed ID: 25604867
[TBL] [Abstract][Full Text] [Related]
3. Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study.
Wang JN; Cao XX; Zhao AL; Cai H; Wang X; Li J
Cancer Cell Int; 2018; 18():187. PubMed ID: 30479566
[TBL] [Abstract][Full Text] [Related]
4. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis.
Hou Z; Ye Q; Qiu M; Hao Y; Han J; Zeng H
Respir Res; 2017 Sep; 18(1):170. PubMed ID: 28886713
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between subpopulations of regulatory T cells in COPD.
Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
[TBL] [Abstract][Full Text] [Related]
6. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.
Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S
Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642
[TBL] [Abstract][Full Text] [Related]
7. Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients.
Arruvito L; Sabatté J; Pandolfi J; Baz P; Billordo LA; Lasala MB; Salomón H; Geffner J; Fainboim L
PLoS One; 2012; 7(12):e52580. PubMed ID: 23285102
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Regulatory T Cell Subsets and Their Expression of Helios and PD-1 in Patients with Hashimoto Thyroiditis.
Hu Y; Zhang L; Chen H; Liu X; Zheng X; Shi H; Jiang L; Cui D
Int J Endocrinol; 2019; 2019():5368473. PubMed ID: 31214258
[TBL] [Abstract][Full Text] [Related]
9. Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension.
Sada Y; Dohi Y; Uga S; Higashi A; Kinoshita H; Kihara Y
Heart Vessels; 2016 Aug; 31(8):1319-26. PubMed ID: 26319442
[TBL] [Abstract][Full Text] [Related]
10. Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis.
Zhang SX; Wang J; Wang CH; Jia RH; Yan M; Hu FY; Liu GY; Liu XY; Luo J; Gao C; Li XF
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211011370. PubMed ID: 33995604
[TBL] [Abstract][Full Text] [Related]
11. Different phenotypes of CD4
Wang K; Song ZL; Wu B; Zhou CL; Liu W; Gao W
Int Immunopharmacol; 2019 Apr; 69():194-201. PubMed ID: 30735938
[TBL] [Abstract][Full Text] [Related]
12. Altered subgroups of regulatory T cells in patients with primary Sjögren's syndrome.
Lin JC; Pan KL; Li CF; Lee KF; Lin KY; Lin KM; Lin CY
Heliyon; 2023 May; 9(5):e15565. PubMed ID: 37153426
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
14. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
[TBL] [Abstract][Full Text] [Related]
15. A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis.
Saito S; Suzuki K; Yoshimoto K; Kaneko Y; Matsumoto Y; Yamaoka K; Takeuchi T
Arthritis Res Ther; 2017 Oct; 19(1):231. PubMed ID: 29041951
[TBL] [Abstract][Full Text] [Related]
16. Changes in the proportion of regulatory T cell subpopulations during menstrual cycle and early pregnancy.
Okimura H; Tanaka Y; Fujii M; Shimura K; Maeda E; Ito F; Khan KN; Nakamura Y; Mori T; Kitawaki J
Am J Reprod Immunol; 2022 Dec; 88(6):e13636. PubMed ID: 36217280
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood.
Wang T; Sun X; Zhao J; Zhang J; Zhu H; Li C; Gao N; Jia Y; Xu D; Huang FP; Li N; Lu L; Li ZG
Ann Rheum Dis; 2015 Jun; 74(6):1293-301. PubMed ID: 24521740
[TBL] [Abstract][Full Text] [Related]
18. Reduction of peripheral regulatory T cells in active rheumatoid arthritis patients with coronary artery disease.
Wang Y; Su R; Li B; Guo Q; Hu F; Yu X; Ma M; Wang L; Gao C; Li X; Wang C
BMC Immunol; 2021 Dec; 22(1):76. PubMed ID: 34915859
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T Cells Fail to Suppress Fast Homeostatic Proliferation In Vitro.
Shevyrev D; Tereshchenko V; Blinova E; Knauer N; Pashkina E; Sizikov A; Kozlov V
Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33809452
[TBL] [Abstract][Full Text] [Related]
20. Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial.
Wang J; Zhang SX; Chang JS; Cheng T; Jiang XJ; Su QY; Zhang JQ; Luo J; Li XF
Front Immunol; 2022; 13():947341. PubMed ID: 36524114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
